title: Prophylactic OKT3, CyA, and steroids versus antilymphoblast globulin, CyA, and steroids in cadaveric kidney transplantation.
authors.affiliation: Department of Nephrology, University of Barcelona, Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Griñó
authors.forename: A M
authors.initials: AM
authors.lastname: Castelao
authors.forename: D
authors.initials: D
authors.lastname: Serón
authors.forename: C
authors.initials: C
authors.lastname: Gonzalez
authors.forename: J M
authors.initials: JM
authors.lastname: Galceran
authors.forename: S
authors.initials: S
authors.lastname: Gil-Vernet
authors.forename: E
authors.initials: E
authors.lastname: Andrés
authors.forename: J
authors.initials: J
authors.lastname: Bover
authors.forename: J
authors.initials: J
authors.lastname: Torras
authors.forename: J
authors.initials: J
authors.lastname: Alsina
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D003131:Combined Modality Therapy; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D003404:Creatinine; D011241:Prednisone; D008775:Methylprednisolone